Related Experiment Video

Updated: Jun 17, 2026

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration
11:13

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration

Published on: June 9, 2023

[Side effects of proliferation signal inhibitors and their management]

E Epailly1, R Lorho

  • 1Service de Chirurgie cardiaque, Les Hôpitaux Universitaires de Strasbourg, 1, place de l'Hôpital, 67000 Strasbourg, France. Eric.Epailly@chru-strasbourg.fr

Gastroenterologie Clinique Et Biologique
|December 17, 2009
PubMed

Insights

Proliferation signal inhibitors (PSI) can reduce calcineurin inhibitor levels, minimizing toxicity and improving graft survival. Understanding and managing PSI side effects like hyperlipidemia and skin issues is crucial for patient outcomes.

Area of Science:

  • Pharmacology
  • Transplantation Medicine
  • Nephrology

Background:

  • Calcineurin inhibitors (CNIs) are vital immunosuppressants post-transplant.
  • CNIs are associated with significant toxicity, impacting long-term graft survival.
  • Proliferation signal inhibitors (PSIs) offer a potential strategy to reduce CNI dosage.

Purpose of the Study:

  • To explore the role of proliferation signal inhibitors (PSIs) in managing calcineurin inhibitor (CNI) levels.
  • To identify and characterize the specific side effects associated with PSI use.
  • To emphasize the importance of early and adapted management of PSI-induced adverse events.

Main Methods:

  • Review of clinical data and literature on PSI and CNI use.
  • Analysis of reported side effect profiles in patients receiving PSIs.
  • Evaluation of management strategies for PSI-related toxicities.

Main Results:

  • PSIs can effectively lower CNI levels, potentially reducing CNI-related toxicity.
  • Common PSI side effects include hyperlipidemia and cutaneous manifestations.
  • Serious adverse events such as angioedema and interstitial pneumonitis can occur.

Conclusions:

  • PSI use is a viable strategy for CNI dose reduction, aiming to improve graft survival.
  • Awareness of specific PSI side effects is essential for safe clinical practice.
  • Timely and appropriate management of PSI-related side effects can mitigate their impact and improve patient outcomes.

More Related Videos

Monitoring PD-1-Blocking Antibodies Bound to T Cells Derived from a Drop of Peripheral Blood06:07

Monitoring PD-1-Blocking Antibodies Bound to T Cells Derived from a Drop of Peripheral Blood

Published on: February 5, 2020

Related Concept Videos

Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists01:23

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...